Management of malignant fungating wounds with a bioactive microfibre gelling technology dressing: an evaluation.
| Autor: | PRAMOD, SUSY, RICE, SUE |
|---|---|
| Předmět: |
TRAUMATOLOGY diagnosis
FUNGATING wounds ORGANIC compounds MEDICAL technology VISUAL analog scale TREATMENT effectiveness CANCER patients MEDICAL protocols SKIN tumors INTERPROFESSIONAL relations CASE studies HEALTH care teams QUALITY of life SURGICAL dressings BANDAGES & bandaging PAIN management T-cell lymphoma IMMUNOTHERAPY |
| Zdroj: | Wounds UK; 2023, Vol. 19 Issue 4, p68-77, 10p |
| Abstrakt: | Aim: In this article, we aim to raise awareness of some of the clinical concerns surrounding the management of oncology wounds, particularly malignant fungating wounds. We will also provide practical wound management recommendations for healthcare professionals to consider when managing this wound type. We aim to assess the potential of a 100% chitosan with bioactive microfibre gelling (BMG™) dressing (MaxioCel®), to support wound management and work in partnership with industry to deliver clinical education on the management of oncology wounds, including malignant fungating wounds. Method: A case study series was undertaken over four weeks, using the chitosan BMG dressing. Results: We recruited 10 patients during the study. The chitosan BMG dressing facilitated a significant improvement in wound tissue type, exudate levels, and periwound skin, as well as reduced malodour. A reduction in patient-reported pain levels was also noted throughout the evaluation process. Conclusion: The introduction of BMG fibre technology demonstrated good outcomes in this patient group, in a short period of time. Importantly for this patient group, the BMG dressing was able to remain in situ during radiotherapy treatment, allowing uninterrupted management of the wounds. [ABSTRACT FROM AUTHOR] |
| Databáze: | Complementary Index |
| Externí odkaz: |
|